Galectins as Novel Regulators of Immune Cell Homeostasis and Infl ammation

Animal Lectins: A Functional View

Volumn , Issue , 2008, Pages 397-416

  Rabinovich, Gabriel A ^a   Toscano, Marta A ^b   Ilarregui, Juan M ^b   Baum, Linda G ^c  

^a KANSAS STATE UNIVERSITY   (United States)

^b INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84971491763     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420006971-38     Document Type: Chapter

References (125)

1. Barondes, S.H., et al., Galectins: A family of animal beta-galactoside-binding lectins, Cell, 76, 597, 1994.
2. Leffler, H., et al., Introduction to galectins, Glycoconj J, 19, 433, 2004.
3. Barondes, S.H., Vertebrate lectins: Properties and functions, in The Lectins: Properties, Functions and Applications in Biology and Medicine, Liener, I.E., Sharon, N. and Goldstein, I.J. Eds., Academic Press, Orlando, FL, 1986, p. 467.
4. Teichberg, V.I., et al., A beta-d-galactoside binding protein from electric organ tissue of Electrophorus electricus, Proc Natl Acad Sci USA, 72, 1383, 1975.
5. Rabinovich, G.A., et al., Galectins and their ligands: Amplifi ers, silencers or tuners of the infl ammatory response?, Trends Immunol, 23, 313, 2002.
6. Cooper, D.N., Galectinomics: Finding themes in complexity, Biochim Biophys Acta, 1572, 209, 2002.
7. Liu, F.T. and Rabinovich, G.A., Galectins as modulators of tumour progression, Nat Rev Cancer, 5, 29, 2005.
8. Brewer, C., Binding and cross-linking properties of galectins, Biochim Biophys Acta, 1572, 255, 2002.
9. Liu, F.T., Patterson, R.J., and Wang, J.L., Intracellular functions of galectins, Biochim Biophys Acta, 1572, 263, 2002.
10. Hirabayashi, J., et al., Oligosaccharide specifi city of galectins: A search by frontal affi nity chromatography, Biochim Biophys Acta, 1572, 232, 2002.
11. Ilarregui, J.M., et al., The coming of age of galectins as immunomodulatory agents: Impact of these carbohydrate binding proteins in T cell physiology and chronic infl ammatory disorders, Ann Rheum Dis, 64 Suppl 4, iv96, 2005.
12. Blaser, C., et al., Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells, Eur J Immunol, 28, 2311, 1998.
13. Rabinovich, G.A., et al., Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: Biochemical and functional characterization, J Immunol, 160, 4831, 1998.
14. Zuniga, E., et al., Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis, J Leukoc Biol, 70, 73, 2001.
15. Garin, M.I., et al., Galectin-1: A key effector of regulation mediated by CD4+ CD25+ T cells, Blood, 109, 2058, 2007.
16. Sugimoto, N., et al., Foxp3-dependent and -independent molecules specifi c for CD25+ CD4+ natural regulatory T cells revealed by DNA microarray analysis, Int Immunol, 18, 1197, 2006.
17. Rabinovich, G.A., Rubinstein, N., and Toscano, M.A., Role of galectins in infl ammatory and immunomodulatory processes, Biochim Biophys Acta, 1572, 274, 2002.
18. Sacchettini, J.C., Baum, L.G., and Brewer, C.F., Multivalent protein-carbohydrate interactions. A new paradigm for supermolecular assembly and signal transduction, Biochemistry, 40, 3009, 2001.
19. Van Parijs, L. and Abbas, A.K., Homeostasis and self-tolerance in the immune system: Turning lymphocytes off, Science, 280, 243, 1998.
20. Hahn, H.P., et al., Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death, Cell Death Differ, 11, 1277, 2004.
21. Matarrese, P., et al., Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fi ssion, J Biol Chem, 280, 6969, 2005.
22. Pace, K.E., et al., CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death, J Immunol, 165, 2331, 2000.
23. Perillo, N.L., et al., Apoptosis of T cells mediated by galectin-1, Nature, 378, 736, 1995.
24. Perillo, N.L., et al., Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes, J Exp Med, 185, 1851, 1997.
25. Rabinovich, G.A., et al., Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a beta-galactoside-binding lectin, J Biochem, 122, 365, 1997.
26. Rabinovich, G.A., et al., Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms, Cell Death Differ, 9, 661, 2002.
27. Nguyen, J.T., et al., CD45 modulates galectin-1-induced T cell death: Regulation by expression of core 2 O-glycans, J Immunol, 167, 5697, 2001.
28. Pace, K.E., et al., Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1, J Immunol, 163, 3801, 1999.
29. Walzel, H., et al., Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells, Glycobiology, 10, 131, 2000.
30. Galvan, M., et al., Expression of a specifi c glycosyltransferase enzyme regulates T cell death mediated by galectin-1, J Biol Chem, 275, 16730, 2000.
31. Amano, M., et al., The ST6Gal I sialyltransferase selectively modifi es N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death, J Biol Chem, 278, 7469, 2003.
32. Rabinovich, et al., Functions of cell surface galectin-glycoprotein lattices, Curr Opin Struct Biol, 17, 513, 2007.
33. Rappl, G., et al., CD4+ CD7-leukemic T cells from patients with Sezary syndrome are protected from galectin-1-triggered T cell death, Leukemia, 16, 840, 2002.
34. Roberts, A.A., et al., Galectin-1-mediated apoptosis in mycosis fungoides: The roles of CD7 and cell surface glycosylation, Mod Pathol, 16, 543, 2003.
35. Cabrera, P.V., et al., Haploinsuffi ciency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death, Blood, 108, 2399, 2006.
36. Rabinovich, G.A., et al., Molecular mechanisms implicated in galectin-1-induced apoptosis: Activation of the AP-1 transcription factor and downregulation of Bcl-2, Cell Death Differ, 7, 747, 2000.
37. Ion, G., et al., Role of p56lck and ZAP70-mediated tyrosine phosphorylation in galectin-1-induced cell death, Cell Death Differ, 12, 1145, 2005.
38. Ion, G., et al., Acid sphingomyelinase mediated release of ceramide is essential to trigger the mitochondrial pathway of apoptosis by galectin-1, Cell Signal, 18, 1887, 2006.
39. Allione, A., et al., Beta-galactoside-binding protein (beta GBP) alters the cell cycle, up-regulates expression of the alpha- and beta-chains of the IFN-receptor, and triggers IFN--mediated apoptosis of activated human T lymphocytes, J Immunol, 161, 2114, 1998.
40. Endharti, A.T., et al., Galectin-1 supports survival of naive T cells without promoting cell proliferation, Eur J Immunol, 35, 86, 2005.
41. Stowell, S.R., et al., Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells, Blood, 109, 219, 2007.
42. Sturm, A., et al., Human galectin-2: Novel inducer of T cell apoptosis with distinct profi le of caspase activation, J Immunol, 173, 3825, 2004.
43. Akahani, S., et al., Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family, Cancer Res, 57, 5272, 1997.
44. Yang, R.Y., Hsu, D.K., and Liu, F.T., Expression of galectin-3 modulates T-cell growth and apoptosis, Proc Natl Acad Sci USA, 93, 6737, 1996.
45. Fukumori, T., et al., CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis, Cancer Res, 63, 8302, 2003.
46. Stillman, B.N., et al., Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death, J Immunol, 176, 778, 2006.
47. Silva-Monteiro, E., et al., Altered expression of galectin-3 induces cortical thymocyte depletion and premature exit of immature thymocytes. Am J Pathol, 170, 546, 2007.
48. Wada, J., et al., Developmental regulation, expression, and apoptotic potential of galectin-9, a betagalactoside binding lectin, J Clin Invest, 99, 2452, 1997.
49. Kashio, Y., et al., Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway, J Immunol, 170, 3631, 2003.
50. Lu, L.H., et al., Characterization of galectin-9-induced death of Jurkat T-cells, J Biochem, 141, 157, 2007.
51. Zhu, C., et al., The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity, Nat Immunol, 6, 1245, 2005.
52. Bernerd, F., Sarasin, A., and Magnaldo, T., Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes, Proc Natl Acad Sci USA, 96, 11329, 1999.
53. Kuwabara, I., et al., Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release, J Biol Chem, 277, 3487, 2002.
54. Hadari, Y.R., et al., Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis, J Cell Sci, 113, 2385, 2000.
55. Yang, R.Y., et al., Cell cycle regulation by galectin-12, a new member of the galectin superfamily, J Biol Chem, 276, 20252, 2001.
56. Vespa, G.N., et al., Galectin-1 specifi cally modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation, J Immunol, 162, 799, 1999.
57. Chung, C.D., et al., Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction, J Immunol, 165, 3722, 2000.
58. Demetriou, M., et al., Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation, Nature, 409, 733, 2001.
59. Hokama, A., et al., Induced reactivity of intestinal CD4(+) T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal infl ammation, Immunity, 20, 681, 2004.
60. Rabinovich, G.A., et al., Specific inhibition of T-cell adhesion to extracellular matrix and proinfl ammatory cytokine secretion by human recombinant galectin-1, Immunology, 97, 100, 1999.
61. van der Leij, J., et al., Dimeric galectin-1 induces IL-10 production in T-lymphocytes: An important tool in the regulation of the immune response, J Pathol, 204, 511, 2004.
62. Baum, L.G., et al., Amelioration of graft versus host disease by galectin-1, Clin Immunol, 109, 295, 2003.
63. Perone, M.J., et al., Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice, J Immunol, 177, 5278, 2006.
64. Rabinovich, G.A., et al., Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis, J Exp Med, 190, 385, 1999.
65. Rubinstein, N., et al., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege, Cancer Cell, 5, 241, 2004.
66. Toscano, M.A., et al., Differential glycosylation of Th1, Th2 and Th-17 effector cells selectively regulates susceptibility to cell death, Nat Immunol, 8, 825, 2007.
67. Santucci, L., et al., Galectin-1 suppresses experimental colitis in mice, Gastroenterology, 124, 1381, 2003.
68. Toscano, M.A., et al., Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-infl ammatory responses, J Immunol, 176, 6323, 2006.
69. Cortegano, I., et al., Galectin-3 down-regulates IL-5 gene expression on different cell types, J Immunol, 161, 385, 1998.
70. Shevach, E.M., CD4+ CD25+ suppressor T cells: More questions than answers, Nat Rev Immunol, 2, 389, 2002.
71. Butcher, E.C. and Picker, L.J., Lymphocyte homing and homeostasis, Science, 272, 60, 1996.
72. He, J. and Baum, L.G., Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration, Lab Iinvest, 86, 578, 2006.
73. Gauthier, L., et al., Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering, Proc Natl Acad Sci USA, 99, 13014, 2002.
74. Rossi, B., et al., Clustering of pre-B cell integrins induces galectin-1-dependent pre-B cell receptor relocalization and activation, J Immunol, 177, 796, 2006.
75. Clark, A.G., et al., Multifunctional regulators of cell growth are differentially expressed in anergic murine B cells, Mol Immunol, 44, 1274, 2007.
76. Acosta-Rodriguez, E.V., et al., Galectin-3 mediates IL-4-induced survival and differentiation of B cells:Functional cross-talk and implications during Trypanosoma cruzi infection, J Immunol, 172, 493, 2004.
77. Gordon, S., Alternative activation of macrophages, Nat Rev Immunol, 3, 23, 2003.
78. Correa, S.G., et al., Opposite effects of galectin-1 on alternative metabolic pathways of l-arginine in resident, infl ammatory, and activated macrophages, Glycobiology, 13, 119, 2003.
79. Barrionuevo, P., et al., A novel function for galectin-1 at the crossroad of innate and adaptive immunity:Galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway, J Immunol, 178, 436, 2007.
80. Zuniga, E., et al., Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages:Modulation of microbicidal activity and survival, Infect Immun, 69, 6804, 2001.
81. Ozaki, K., et al., Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro, Nature, 429, 72, 2004.
82. Hsu, D.K., et al., Targeted disruption of the galectin-3 gene results in attenuated peritoneal infl ammatory responses, Am J Pathol, 156, 1073, 2000.
83. Sano, H., et al., Critical role of galectin-3 in phagocytosis by macrophages, J Clin Invest, 112, 389, 2003.
84. Sano, H., et al., Human galectin-3 is a novel chemoattractant for monocytes and macrophages, J Immunol, 165, 2156, 2000.
85. Bernardes, E.S., et al., Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity, Am J Pathol, 168, 1910, 2006.
86. Jouault, T., et al., Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling, J Immunol, 177, 4679, 2006.
87. Pelletier, I. and Sato, S., Specific recognition and cleavage of galectin-3 by Leishmania major through species-specifi c polygalactose epitope, J Biol Chem, 277, 17663, 2002.
88. John, C.M., et al., Galectin-3 binds lactosaminylated lipooligosaccharides from Neisseria gonorrhoeae and is selectively expressed by mucosal epithelial cells that are infected, Cell Microbiol, 4, 649, 2002.
89. Fulcher, J.A., et al., Galectin-1-matured human monocyte-derived dendritic cells have enhanced migration through extracellular matrix, J Immunol, 177, 216, 2006.
90. Levroney, E.L., et al., Novel innate immune functions for galectin-1: Galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinfl ammatory cytokines, J Immunol, 175, 413, 2005.
91. Perone, M.J., et al., Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells, J Immunol, 176, 7207, 2006.
92. Dai, S.Y., et al., Galectin-9 induces maturation of human monocyte-derived dendritic cells, J Immunol, 175, 2974, 2005.
93. Vray, B., et al., Up-regulation of galectin-3 and its ligands by Trypanosoma cruzi infection with modulation of adhesion and migration of murine dendritic cells, Glycobiology, 14, 647, 2004.
94. La, M., et al., A novel biological activity for galectin-1: Inhibition of leukocyte-endothelial cell interactions in experimental infl ammation, Am J Pathol, 163, 1505, 2003.
95. Rabinovich, G.A., et al., Evidence of a role for galectin-1 in acute infl ammation, Eur J Immunol, 30, 1331, 2000.
96. Colnot, C., et al., Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice, Immunology, 94, 290, 1998.
97. Almkvist, J., et al., Activation of the neutrophil nicotinamide adenine dinucleotide phosphate oxidase by galectin-1, J Immunol, 168, 4034, 2002.
98. Karlsson, A., et al., Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutro phils, Blood, 91, 3430, 1998.
99. Kuwabara, I. and Liu, F.T., Galectin-3 promotes adhesion of human neutrophils to laminin, J Immunol, 156, 3939, 1996.
100. Sato, S., et al., Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia, J Immunol, 168, 1813, 2002.
101. Nieminen, J., St-Pierre, C., and Sato, S., Galectin-3 interacts with naive and primed neutrophils, inducing innate immune responses, J Leukoc Biol, 78, 1127, 2005.
102. Fernandez, G.C., et al., Galectin-3 and soluble fi brinogen act in concert to modulate neutrophil activation and survival: Involvement of alternative MAPK pathways, Glycobiology, 15, 519, 2005.
103. Gil, C.D., et al., Infl ammation-induced modulation of cellular galectin-1 and -3 expression in a model of rat peritonitis, Infl amm Res, 55, 99, 2006.
104. Nishi, N., et al., Galectin-8 modulates neutrophil function via interaction with integrin alphaM, Glycobiology, 13, 755, 2003.
105. Delbrouck, C., et al., Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration, Lab Invest, 82, 147, 2002.
106. Matsumoto, R., et al., Biological activities of ecalectin: A novel eosinophil-activating factor, J Immunol, 168, 1961, 2002.
107. Saita, N., et al., Association of galectin-9 with eosinophil apoptosis, Int Arch Allergy Immunol, 128, 42, 2002.
108. Zuberi, R.I., Frigeri, L.G., and Liu, F.T., Activation of rat basophilic leukemia cells by epsilon BP, an IgE-binding endogenous lectin, Cell Immunol, 156, 1, 1994.
109. Chen, H.Y., et al., Role of galectin-3 in mast cell functions: Galectin-3-defi cient mast cells exhibit impaired mediator release and defective JNK expression, J Immunol, 177, 4991, 2006.
110. Levi, G., Tarrab-Hazdai, R., and Teichberg, V.I., Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits, Eur J Immunol, 13, 500, 1983.
111. Offner, H., et al., Recombinant human beta-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis, J Neuroimmunol, 28, 177, 1990.
112. Santucci, L., et al., Galectin-1 exerts immunomodulatory and protective effects on concanavalin-Ainduced hepatitis in mice, Hepatology, 31, 399, 2000.
113. Tsuchiyama, Y., et al., Effi cacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats, Kidney Int, 58, 1941, 2000.
114. Romero, M.D., et al., Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis, Invest Ophthalmol Vis Sci, 47, 1550, 2006.
115. Thijssen, V.L., et al., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy, Proc Natl Acad Sci USA, 103, 15975, 2006.
116. Baba, M., et al., Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycledependent mechanisms, J Am Soc Nephrol, 16, 3222, 2005.
117. Lopez, E., et al., Inhibition of chronic airway infl ammation and remodeling by galectin-3 gene therapy in a murine model, J Immunol, 176, 1943, 2006.
118. Zuberi, R.I., et al., Critical role for galectin-3 in airway infl ammation and bronchial hyperresponsiveness in a murine model of asthma, Am J Pathol, 165, 2045, 2004.
119. Rabinovich, G.A., Gabrilovich, D., and Sotomayor, E.M., Immunosuppressive strategies that are mediated by tumor cells, Annu Rev Immunol, 25, 267, 2007.
120. Camby, I., et al., Galectin-1: A small protein with major functions, Glycobiology, 16, 137R, 2006.
121. Le, Q.T., et al., Galectin-1: A link between tumor hypoxia and tumor immune privilege, J Clin Oncol, 23, 8932, 2005.
122. Daroqui, C.M., et al., Regulation of galectin-1 expression by transforming growth factor beta1 in metastatic mammary adenocarcinoma cells: Implications for tumor-immune escape, Cancer Immunol Immunother, 56, 491, 2007.
123. Zacarias Fluck, M.F., et al., Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model, Cancer Immunol Immunother, 56, 237, 2007.
124. Parsonage, G., et al., Roles of galectins in chronic infl ammatory microenvironments, Future Rheumatol, 1, 441, 2006.
125. Ingrassia, L., et al., Anti-galectin compounds as potential anti-cancer drugs, Curr Med Chem, 13, 3513, 2006.